M. Shteinberg (Haifa, Israel), Z. Alfahl (Galway, Ireland)
Etiology of Bronchiectasis in Adults in Ukraine
K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
|   |
Mortality related risk factors in patients with non-cystic fibrosis bronchiectasis
O. Munteanu (Chi?inau (Chi?inau), Republic of Moldova), D. Chesov (Chi?inau (Chi?inau), Republic of Moldova), D. Rusu (Chi?inau (Chi?inau), Republic of Moldova), L. Onea (Chi?inau (Chi?inau), Republic of Moldova), V. Botnaru (Chi?inau (Chi?inau), Republic of Moldova)
| |
Particularities of post-tuberculosis bronchiectasis
S. Ben Sassi (Ariana, Tunisia), H. Rouis (Ariana, Tunisia), C. Moussa (Ariana, Tunisia), M. Bougacha (Ariana, Tunisia), A. Khattab (Ariana, Tunisia), I. Khouaja (Ariana, Tunisia), L. Bayahi (Ariana, Tunisia), I. Zendah (Ariana, Tunisia), S. Maalej (Ariana, Tunisia), I. Khouaja (Tunis, Tunisia)
| |
Determinants of Quality of Life using the bronchiectasis impact measure (BIM)
M. Crichton (Dundee (Angus), United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)
| |
Risk factors for Pseudomonas aeruginosa colonization bronchiectasis and clinical implications
R. Jebali (ARIANA, Tunisia), I. Moussa (ARIANA, Tunisia), I. Sahnoun (ARIANA, Tunisia), S. Rejeb (ARIANA, Tunisia), M. Bougacha (ARIANA, Tunisia), L. Douik El Gharbi (ARIANA, Tunisia), L. Douik El Gharbi (Ariana, Tunisia)
| |
Initiating NIV in bronchiectasis – Is it a sign of poor life expectancy?
A. Chudasama (London, United Kingdom), F. Dickens (Sheffield, United Kingdom), T. Khan (London, United Kingdom), R. Dexter-Spooncer (Sheffield, United Kingdom), A. Shah (London, United Kingdom), J. Stowell (London, United Kingdom), M. Loebinger (London, United Kingdom), A. Manuel (Sheffield, United Kingdom), S. Iyer (Sheffield, United Kingdom), M. Polkey (London, United Kingdom), R. José (London, United Kingdom)
| |
Effect of COVID-19 on non-cystic fibrosis bronchiectasis exacerbation rates: a retrospective claims study
A. Åstrand (Mölndal, Sweden), S. Kiddle (Evanston, United States), R. Mudedla (Evanston, United States), S. Porwal (Evanston, United States), K. Chafekar (Evanston, United States), C. Seminario (Gaithersburg, United States), J. Chalmers (Dundee, United Kingdom), I. Psallidas (Cambridge, United Kingdom), I. Psallidas (London, United Kingdom)
| |
Association between the viscoelastic characteristics and sputum colour in patients with bronchiectasis
L. Bueno-Freire (Barcelona, Spain), N. Rovira (Barcelona, Spain), V. Alcaraz-Serrano (Barcelona, Spain), H. Sanz-Fraile (Barcelona, Spain), N. Vàzquez-Burgos (Barcelona, Spain), R. Amaro-Rodríguez (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), A. Palomeque (Barcelona, Spain), R. Farré (Barcelona, Spain), J. Otero (Barcelona, Spain), L. Fernández-Barat * (Barcelona, Spain), A. Torres* (Barcelona, Spain)
| |
Bacteriological profile of bronchiectasis superinfections
H. Bamha (casablanca, Morocco), H. Arfaoui (casablanca, Morocco), H. Jabri (casablanca, Morocco), W. El Khattabi (casablanca, Morocco), M. Afif (casablanca, Morocco)
| |
Do adults with Primary Ciliary Dyskinesia (PCD) have a positive experience of home spirometry?
S. Peake (London, United Kingdom), A. Jones (London, United Kingdom), R. Jose (London, United Kingdom), E. Shattock (London, United Kingdom), M. Loebinger (London, United Kingdom)
| |
Clinical outcomes of bronchiectasis rheumatoid overlap syndrome in Taiwan
H. Huang (Taipei, Taiwan), M. Hsieh (Taipei, Taiwan), J. Huang (Taipei, Taiwan), F. Chung (Taipei, Taiwan), C. Wang (Taipei, Taiwan), H. Lin (Taipei, Taiwan)
| |
Assessment of a self-administered home intravenous antimicrobial therapy service for patients with chronic suppurative lung disease
G. Lamb (London, United Kingdom), S. Stoll (London, United Kingdom), R. Jose (London, United Kingdom), M. Loebinger (London, United Kingdom), A. Shah (London, United Kingdom), J. Stowell (London, United Kingdom)
| |
Improving Physiotherapy Care of Bronchiectasis Inpatients
J. Kilduff (London, United Kingdom), A. Ahmad (London, United Kingdom), L. Grillo (London, United Kingdom), J. Stowell (London, United Kingdom)
| |
Regional features of Pseudomonas aeruginosaPA) antibiotic (AB) resistance (R) in patients (pts) with bronchiectasis (Bx)
K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
| |
Late Breaking Abstract - Microbiome characterization in patients with bronchiectasis and its association with severity and bronchial inflammation. Bronchi-Omics Project.
F. Gonçalves Dos Santos Carvalho (Barcelona, Spain), T. Zapata Comas (Barcelona, Spain), L. Rodríguez Pons (Barcelona, Spain), S. Quero Blanca (Barcelona, Spain), E. Barreiro Portela (Barcelona, Spain), L. Quin (Barcelona, Spain), A. Navarro Rolon (Terrassa, Spain), J. Pomares Amigó (Sabadell, Spain), C. Montón Soler (Sabadell, Spain), M. Vendrell Relat (Girona, Spain), G. Muñoz Castro (Girona, Spain), E. Polverino (Barcelona, Spain), A. Llunell Casanoves (Terrassa, Spain), G. Suarez Cuartin (Barcelona, Spain), C. Calero Acuña (Sevilla, Spain), J. Abad Capa (Barcelona, Spain), A. Rosell Gratacós (Barcelona, Spain), A. Marin Tapia (Barcelona, Spain)
| |
Late Breaking Abstract - Optimizing the diagnostic approach for Primary Ciliary Dyskinesia with normal ultrastructure
J. Raidt (Münster, Germany), H. Krenz (Münster, Germany), J. Tebbe (Münster, Germany), J. Große-Onnebrink (Münster, Germany), H. Olbrich (Münster, Germany), N. Loges (Münster, Germany), L. Biebach (Münster, Germany), C. Schmalstieg (Münster, Germany), C. Keßler (Münster, Germany), J. Wallmeier (Münster, Germany), B. Dworniczak (Münster, Germany), P. Pennekamp (Münster, Germany), M. Dugas (Heidelberg, Germany), C. Werner (Schwerin, Germany), H. Omran (Münster, Germany)
| |